Drug Type Chemical drugs |
Synonyms WQE 134, WQE134 |
Target |
Action antagonists, inhibitors |
Mechanism PGE2 antagonists(Prostaglandin E2 antagonists), Nitric oxide inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | Czechia | 28 Aug 2020 | |
Inflammation | Preclinical | Czechia | 28 Aug 2020 |